Archive · 19 Nov 2025
India's First Cell & Gene Therapy Training Program Launched
India's first hands-on training program for cell and gene therapy has started.
This program, led by BRIC-THSTI, Miltenyi Biotec, and BIRAC, teaches early-career scientists and clinicians about CAR-T cell therapy.
It covers everything from research to making sure treatments are safe for patients.
The goal is to help India's medical field catch up with the rest of the world in this area.
BRIC-THSTI, Miltenyi Biotec, and BIRAC launched India's first hands-on cell and gene therapy training program
Program focuses on CAR-T cell therapy and covers pre-clinical development to clinical translation
Aimed at early-career scientists and clinicians to bridge research and clinical application gap
Training includes practical experience in GMP-compliant manufacturing
Program is a pioneering initiative in India's cell and gene therapy landscape
- Who
- BRIC-THSTI, Miltenyi Biotec, BIRAC, early-career scientists and clinicians
- What
- Launched India's first hands-on training program on cell and gene therapy
- When
- Not specified
- Where
- Hyderabad
- Why
- To bridge the gap between research and clinical application in cell and gene therapy
- Institution
- BRIC-Translational Health Science and Technology Institute (BRIC-THSTI)
- Partners
- Miltenyi Biotec and Biotechnology Industry Research Assistance Council (BIRAC)
- Focus
- Foundations of Cell and Gene Therapy (CGT) Manufacturing, with a special focus on CAR-T cell therapy
- Audience
- Early-career scientists and clinicians
- Coverage
- Pre-clinical development, GMP-compliant manufacturing, and clinical translation